These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 34103615)

  • 1. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease.
    Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y
    Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
    Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
    J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice.
    Zhang YH; Mann D; Raymick J; Sarkar S; Paule MG; Lahiri DK; Dumas M; Bell-Cohen A; Schmued LC
    Curr Alzheimer Res; 2014 Mar; 11(3):299-308. PubMed ID: 24552157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of insoluble Amyloid-β with soluble Amyloid-β dimers decreases Amyloid-β plaque numbers.
    van Gerresheim EF; Herring A; Gremer L; Müller-Schiffmann A; Keyvani K; Korth C
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):603-610. PubMed ID: 33338256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Anti-amyloid Compound DO1 Decreases Plaque Pathology and Neuroinflammation-Related Expression Changes in 5xFAD Transgenic Mice.
    Boeddrich A; Babila JT; Wiglenda T; Diez L; Jacob M; Nietfeld W; Huska MR; Haenig C; Groenke N; Buntru A; Blanc E; Meier JC; Vannoni E; Erck C; Friedrich B; Martens H; Neuendorf N; Schnoegl S; Wolfer DP; Loos M; Beule D; Andrade-Navarro MA; Wanker EE
    Cell Chem Biol; 2019 Jan; 26(1):109-120.e7. PubMed ID: 30472115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Saul A; Wirths O
    Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally Administered Benzofuran Derivative Disaggregated Aβ Plaques and Oligomers in the Brain of 5XFAD Alzheimer Transgenic Mouse.
    Kim D; Bae GH; Kim HY; Jeon H; Kim K; Shin J; Lee S; Hong S; Kim I; Kim Y
    ACS Chem Neurosci; 2021 Jan; 12(1):99-108. PubMed ID: 33332107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.
    Chuang JY; Lee CW; Shih YH; Yang T; Yu L; Kuo YM
    PLoS One; 2012; 7(3):e33120. PubMed ID: 22412990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.